Abstract
Owing to their inherent structural features, certain sulfated glycans isolated from terrestrial or marine mammals or invertebrates, can exert therapeutic properties against infections caused by pathogenic microorganisms like bacteria, virus, fungus, and protozoan parasites. These sulfated glycans belong to a variety of classes including glycosaminoglycans (GAGs) like chondroitin sulfate, fucosylated chondroitin sulfate, dermatan sulfate, unfractionated heparin, low-molecular-weight heparin, and acharan sulfate; and the less-famous algal polysaccharides known as sulfated fucans (including fucoidans), sulfated galactans (agarans and carrageenans), and sulfated heteropolysaccharides. Administration at certain concentrations of the antimicrobial sulfated glycans, especially those containing the higher amounts of the bioactive structural requirements, can lead to the interruption or disruption of the pathogen protein-host GAG complex formation, leading thus to the decrease or impairment of the microbial binding onto host cells. This report aims at presenting the current background concerning the therapeutic effects of the above-mentioned sulfated glycans as new antimicrobial agents. When sufficient data are available, discussion regarding structure-activity relationship is provided.
Keywords: Antibacterial, Antifungal, Antiprotozoan, Antiviral, Carbohydrate-based drug discovery, Carbohydrate-based drug development, Glycosaminoglycans, Sulfated glycans.
Current Topics in Medicinal Chemistry
Title:Antimicrobial Sulfated Glycans: Structure and Function
Volume: 17 Issue: 3
Author(s): Vitor H. Pomin
Affiliation:
Keywords: Antibacterial, Antifungal, Antiprotozoan, Antiviral, Carbohydrate-based drug discovery, Carbohydrate-based drug development, Glycosaminoglycans, Sulfated glycans.
Abstract: Owing to their inherent structural features, certain sulfated glycans isolated from terrestrial or marine mammals or invertebrates, can exert therapeutic properties against infections caused by pathogenic microorganisms like bacteria, virus, fungus, and protozoan parasites. These sulfated glycans belong to a variety of classes including glycosaminoglycans (GAGs) like chondroitin sulfate, fucosylated chondroitin sulfate, dermatan sulfate, unfractionated heparin, low-molecular-weight heparin, and acharan sulfate; and the less-famous algal polysaccharides known as sulfated fucans (including fucoidans), sulfated galactans (agarans and carrageenans), and sulfated heteropolysaccharides. Administration at certain concentrations of the antimicrobial sulfated glycans, especially those containing the higher amounts of the bioactive structural requirements, can lead to the interruption or disruption of the pathogen protein-host GAG complex formation, leading thus to the decrease or impairment of the microbial binding onto host cells. This report aims at presenting the current background concerning the therapeutic effects of the above-mentioned sulfated glycans as new antimicrobial agents. When sufficient data are available, discussion regarding structure-activity relationship is provided.
Export Options
About this article
Cite this article as:
Pomin H. Vitor, Antimicrobial Sulfated Glycans: Structure and Function, Current Topics in Medicinal Chemistry 2017; 17 (3) . https://dx.doi.org/10.2174/1568026615666150605104444
DOI https://dx.doi.org/10.2174/1568026615666150605104444 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Apoptosis-related BCL2-family Members: Key Players in Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Current Cancer Drug Targets NK Cell Receptor and MHC Gene Polymorphisms, Potential Relevance in Malignancies
Current Cancer Therapy Reviews Sphingolipid Metabolism Enzymes as Targets for Anti-Cancer Therapy
Current Drug Targets Implication of Possible Therapies Targeted for the Tachykinergic System with the Biology of Neurokinin Receptors and Emerging Related Proteins
Recent Patents on CNS Drug Discovery (Discontinued) Key miRNAs in Modulating Aging and Longevity: A Focus on Signaling Pathways and Cellular Targets
Current Molecular Pharmacology Estrogen Activates Classical and Alternative Mechanisms to Orchestrate Neuroprotection
Current Neurovascular Research Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia
Current Cancer Therapy Reviews CD36 as a Multiple-Ligand Signaling Receptor in Atherothrombosis
Cardiovascular & Hematological Agents in Medicinal Chemistry A New Investigational Perspective for Purines Against Glioblastoma Invasiveness
Current Drug Targets The High Throughput Biomedicine Unit at the Institute for Molecular Medicine Finland: High Throughput Screening Meets Precision Medicine
Combinatorial Chemistry & High Throughput Screening Biosafety of Onco-Retroviral Vectors
Current Gene Therapy Psychotropic Medications and the Treatment of Human Prion Diseases
CNS & Neurological Disorders - Drug Targets Autophagy and Cell Death in Caenorhabditis elegans
Current Pharmaceutical Design MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics
Current Pharmaceutical Design Base Excision Repair: Contribution to Tumorigenesis and Target in Anticancer Treatment Paradigms
Current Medicinal Chemistry The Chemistry of Bioactive Diterpenes
Current Organic Chemistry Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Current Pharmaceutical Design Microwave-Assisted Domino Cyclization Reactions
Current Microwave Chemistry Prostaglandin J2 Family and the Cardiovascular System
Current Vascular Pharmacology